Illinois News Joint

OCTOBER 10, 2024

Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Increase public outreach with the industry, newcomers to cannabis, advocacy groups, and the general public.

Seed-To-Sale 110

Seed-To-Sale Data Dispensary Agriculture 110

NORML

MARCH 27, 2020

A majority of Americans agree with states’ decisions to classify licensed medical cannabis facilities as “essential services” to the community – a designation that permits them to maintain retail operations during regional ‘stay-at-home’ orders.

Dispensary 286

Dispensary Policy Access Retail 286

NORML

JUNE 10, 2019

Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse.

Chronic Pain 277

Chronic Pain Access Collective Medicine 277

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 355

Chronic Pain Clinical Trials Data Patients 355

NORML

NOVEMBER 1, 2022

“Legalizing and regulating cannabis provides for more job opportunities, greater tax revenues, and safe access to high quality products at increasingly affordable prices,” NORML’s State Policy Manager Jax James said. This economic data shows once again why legalization is a preferable policy option over criminal prohibition.".

Legalization 49

Legalization Data Policy Access 49

Canna Care Docs

OCTOBER 10, 2024

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? Rescheduling would stand to have the largest impact on cannabis research and business taxes.

Patients 111

Patients DEA Research and Development Recreational 111

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.

CBD 317

CBD Clinical Trials Data Treatment 317

NORML

APRIL 27, 2020

The Coalition letter focuses on the need for small business access to the SBA relief funds as an avenue to protect the progress that has been made by minority entrepreneurs in the emerging legal cannabis marketplaces. You can read NORML’s factsheet on the racial disparity among arrests here. You can read the full letter below.

Business 329

Business Access Policy Programs 329

NORML

AUGUST 20, 2019

The self-reported use of marijuana by teenagers continues to decline nationally, according to federal data reported by the United States Substance Abuse and Mental Health Services Administration (SAMHSA). By contrast, self-reported cannabis use by older Americans has risen during this same time period. percent to 12.5 percent to 12.5

Marijuana 246

Marijuana Data Access Environment 246

NORML

FEBRUARY 26, 2019

While most of the recent media conversation around cannabis and the Super Bowl surrounded the ability for a medical marijuana company’s attempt to air an advertisement, one of the issues raised by various NORML members over the last few weeks has been more focused on the actual well-being of the players themselves.

Access 208

Access Medicine Policy Media 208

NORML

FEBRUARY 28, 2020

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. The annual revenues related to medical cannabis now total more than the total revenues generated by the sales of blueberries, maple syrup, apples, herring, and oysters combined.

Data 232

Data Patients Retail Programs 232

NORML

APRIL 12, 2020

According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.

Decriminalization 364

Decriminalization Legalization Marijuana Legislation 364

NORML

AUGUST 29, 2019

Remarks made today by the United States Surgeon General highlighting “the importance of protecting our nation from the health risks of marijuana use in adolescents and during pregnancy” fail to acknowledge the role that a regulated market can play in mitigating the use of cannabis by potentially high-risk populations.

Education 246

Education Data Retail Environment 246

NORML

DECEMBER 29, 2020

According to statewide polling data, 90 percent of Kentucky residents support regulating medical marijuana access. The post States to Watch in 2021: Kentucky appeared first on NORML.

Data 246

Data Access Marijuana Cannabis 246

The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Here’s what they found.

Sleep 137

Sleep Data Tincture Research and Development 137

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 215

Clinical Trials Chronic Pain Data Treatment 215

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

MAY 21, 2020

According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.

Decriminalization 364

Decriminalization Marijuana Legislation Oil 364

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 231

Retail Sleep History Medicine 231

NORML

JANUARY 29, 2020

Nearly Two-Thirds of US Governors Receive a Passing Grade on Cannabis Policy. No Republicans are on record in support of adult-use legalization and few are in favor of regulating medical cannabis access. NORML has released its 2020 Gubernatorial Scorecard. ” KEY FINDINGS. ” Read the 2020 Scorecard online here.

Policy 360

Policy Legislation Data Access 360

Canna Law Blog

MARCH 25, 2025

Australia Cannabis Q&A A. Is cannabis legal for business purposes in Australia? Growing cannabis for personal use remains illegal in most Australian states and territories. Industrial hemp (low-THC cannabis) is regulated under separate licensing frameworks in most Australian jurisdictions.

Research and Development 90

Research and Development Medicine Compliance Compliance 90

Cannabis Life Network

SEPTEMBER 16, 2022

BDSA’s latest report suggests that recreational cannabis access affects longer standing medical market. Access with a medical card encourages patients to buy heavily taxed adult-use cannabis. But is recreational access a benefit or hinderance on medical cannabis?

Access 109

Access Recreational Patients Cannabis 109

NORML

MAY 23, 2019

Seniors who report the use of cannabis over the past year say that it improves their overall quality of life, according to survey data published in the journal Gerontology & Geriatric Medicine. years) regarding their cannabis use patterns.

Topical 216

Topical Data Edibles Medicine 216

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 225

Chronic Pain Patients Therapy Data 225

NORML

MARCH 7, 2019

Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment. If it helps veterans, it can help all Americans.

Legislation 261

Legislation Marijuana Policy Research and Development 261

Cannabis Law Report

DECEMBER 18, 2020

15, 2020 /PRNewswire/ — CME Group, the world’s leading and most diverse derivatives marketplace, today announced that customers can now access hemp … Read More. The post CME Group Adds New Hemp Pricing Data to CME DataMine first appeared on Cannabis Law Report. CHICAGO , Dec.

Data 98

Data Hemp Access Law 98

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 277

Clinical Trials Chronic Pain Cannabinoids Patients 277

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.

Data 115

Data Research and Development Patients Strains 115

The Cannigma

NOVEMBER 24, 2022

What if you could get paid to consume cannabis and fall asleep? Join this cannabis sleep study from home. Cannabis science is a growing field, but People Science thinks it can be done on a wider, more collective scale, so it’s bringing the research tools right to your phone. 7 fascinating ways cannabis can affect your body.

Sleep 105

Sleep Collective Data Tincture 105

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 260

Chronic Pain Therapy Patients Topical 260

Illinois News Joint

MARCH 24, 2025

The Illinois Department of Agriculture (IDOA) and the Division of Cannabis Regulation announced today an official Metrc implementation timeline for licensed cannabis businesses transitioning from BioTrack to Metrc as Illinois’ track-and-trace data system. To find cannabis-friendly events in Illinois, visit here.

Supply Chain 82

Supply Chain Agriculture Packaging Dispensary 82

NORML

FEBRUARY 28, 2019

First off, I want to thank you for being an active member of the cannabis reform movement and I am proud to tell you that we have never been closer to ending the counterproductive and cruel policy of marijuana criminalization than we are right now. Congresswoman Barbara Lee represents California’s 13th district.

Marijuana 273

Marijuana Access Legislation Policy 273

Cannabis Law Report

DECEMBER 27, 2019

If you thought there was no relationship between cannabis use and technology, consider these stats: the average number of mobile apps being used in a day by current cannabis users are 4. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 247

Cannabinoids Data Safety Patients 247

Americans for Safe Access

JANUARY 12, 2024

We are hopeful that the DEA will agree with HHS’ recommendation to change cannabis’ status and that Congress views HHS’ report as a greenlight to move forward with a more comprehensive approach to medical cannabis access.” ASA’s recommendation to FDA for scheduling can be found here.

DEA 130

DEA Media Access Data 130

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). 19 August 2021.

Data 105

Data Access Medicine Patients 105

NORML

MARCH 28, 2019

Currently, thousands of state-licensed and regulated businesses lack access to the banking industry and are unable to accept credit cards, deposit revenues, or write checks to meet payroll or pay taxes because federal law discourages financial institutions from engaging in such partnerships. Thirty-three states, Washington, D.C. and the U.S.

Banking 279

Banking Marijuana Policy Safety 279